An advisory panel for the Centers for Medicare and Medicaid Services expressed low confidence in low-dose computed tomography as a method for screening for lung cancer in the Medicare population.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
